[¹²³I]β-CIT SPECT Visualizes Dopamine Transporter Loss in de novo Parkinsonian Patients

Publisher： Karger

E-ISSN： 1421-9913|39|1|44-48

ISSN： 0014-3022

Source： European Neurology, Vol.39, Iss.1, 1998-01, pp. : 44-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Impairment of the Striatal Dopamine Transporter System in Sporadic Olivopontocerebellar Atrophy: Studied with [¹²³I]β-CIT and SPECT

European Neurology, Vol. 43, Iss. 1, 2000-01 ,pp. : 23-29

Karger

Access to resources Recommend Favorite

Camptocormia in Idiopathic Parkinson’s Disease: [¹²³I]β-CIT SPECT and Clinical Characteristics

European Neurology, Vol. 50, Iss. 2, 2003-09 ,pp. : 118-120

Karger

Access to resources Recommend Favorite

Diagnostic Value of ¹²³I-Ioflupane and ¹²³I-Iodobenzamide SPECT Scans in 248 Patients with Parkinsonian Syndromes

European Neurology, Vol. 59, Iss. 5, 2008-02 ,pp. : 258-266

Karger

Access to resources Recommend Favorite

Diagnosis of Hallervorden-Spatz Disease Using MRI, ¹²³I-Beta-CIT-SPECT and ¹²³I-IBZM-SPECT

European Neurology, Vol. 43, Iss. 3, 2000-04 ,pp. : 187-188

Karger

Access to resources Recommend Favorite

Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson’s Disease: A Study with ⁶²Cu-ATSM PET and ¹²³I-FP-CIT SPECT

European Neurology, Vol. 78, Iss. 3-4, 2017-08 ,pp. : 161-168

Karger

Access to resources Recommend Favorite